Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Samsung Biologics | Seoul | Healthcare | Pharmaceuticals | ₩73.31T | 57x | 2.21 | ₩1,030,000 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27.2% Upside | Upgrade to Pro+ | |
Alteogen | KOSDAQ | Healthcare | Pharmaceuticals | ₩24.77T | 273.6x | 0.04 | ₩475,500 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22% Upside | Upgrade to Pro+ | |
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.84T | 114.6x | -2.27 | ₩105,500 | 0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Yuhan | Seoul | Healthcare | Pharmaceuticals | ₩8.84T | 114.6x | -2.27 | ₩119,000 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.1% Upside | Upgrade to Pro+ | |
Sk Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩8.38T | 30.3x | 0.05 | ₩109,200 | 2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 37.4% Upside | Upgrade to Pro+ | |
Pharma Reaserch Products | KOSDAQ | Healthcare | Pharmaceuticals | ₩6.55T | 50.8x | 1.16 | ₩630,000 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 27% Upside | Upgrade to Pro+ | |
Sam Chun Dang Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩4.65T | -296.6x | 1.81 | ₩200,000 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hanmi Pharm Co | Seoul | Healthcare | Pharmaceuticals | ₩3.87T | 35.8x | -0.86 | ₩305,500 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.5% Upside | Upgrade to Pro+ | |
SK Bioscience Co | Seoul | Healthcare | Pharmaceuticals | ₩3.68T | -71.1x | 0.24 | ₩50,100 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -24.2% Downside | Upgrade to Pro+ | |
Hugel | KOSDAQ | Healthcare | Pharmaceuticals | ₩3.61T | ₩332,000 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 38.6% Upside | Upgrade to Pro+ | |||
Caregen | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.66T | 86.6x | -8.08 | ₩54,500 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -30.3% Downside | Upgrade to Pro+ | |
Hanmi Science | Seoul | Healthcare | Pharmaceuticals | ₩2.66T | 46x | -0.94 | ₩39,300 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Celltrion Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩2.28T | 88.9x | ₩52,400 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
ST Pharm | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.97T | 54.9x | 1.18 | ₩98,000 | -1.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.4% Upside | Upgrade to Pro+ | |
Daewoong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.66T | 21.1x | -1.2 | ₩144,300 | 1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 45.5% Upside | Upgrade to Pro+ | |
Hanall Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.62T | 634.9x | 4.97 | ₩31,950 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 34.6% Upside | Upgrade to Pro+ | |
Oscotec | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.61T | 3.2 | ₩42,100 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33% Upside | Upgrade to Pro+ | ||
GC Biopharma | Seoul | Healthcare | Pharmaceuticals | ₩1.5T | 0.07 | ₩131,000 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Mezzion Pharma | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.46T | -50.9x | 0.34 | ₩51,200 | 0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Nature Cell | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.37T | -634.4x | -10.15 | ₩21,200 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HK Inno.N | KOSDAQ | Healthcare | Pharmaceuticals | ₩1.33T | ₩46,800 | 1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Chong Kun Dang Pharma | Seoul | Healthcare | Pharmaceuticals | ₩1.07T | 17.5x | -0.25 | ₩81,200 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.5% Upside | Upgrade to Pro+ | |
Daewoong | Seoul | Healthcare | Pharmaceuticals | ₩997.73B | 11.7x | -0.4 | ₩24,400 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 14.8% Upside | Upgrade to Pro+ | |
Medy-Tox | KOSDAQ | Healthcare | Pharmaceuticals | ₩852.86B | 42.7x | 0.15 | ₩121,500 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 48.1% Upside | Upgrade to Pro+ | |
Dongkook Pharmaceutical | KOSDAQ | Healthcare | Pharmaceuticals | ₩758.66B | 12.6x | ₩16,980 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.5% Upside | Upgrade to Pro+ | ||
Boryung Pharm | Seoul | Healthcare | Pharmaceuticals | ₩725.69B | 20.5x | -0.38 | ₩8,590 | 1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Donga Socio Holdings | Seoul | Healthcare | Pharmaceuticals | ₩710.5B | 7.7x | 0.11 | ₩110,400 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 31.3% Upside | Upgrade to Pro+ | |
Green Cross Holdings | Seoul | Healthcare | Pharmaceuticals | ₩697.08B | 5.8x | 0.02 | ₩27,300 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Green Cross | Seoul | Healthcare | Pharmaceuticals | ₩697.08B | 5.8x | 0.02 | ₩15,290 | -1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Il Dong Pharma | Seoul | Healthcare | Pharmaceuticals | ₩694.87B | -256.6x | -3.34 | ₩22,500 | -4.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Pharmaceutical Co | Seoul | Healthcare | Pharmaceuticals | ₩663.77B | -64.9x | -0.83 | ₩23,550 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shinpoong Phar | Seoul | Healthcare | Pharmaceuticals | ₩663.77B | -64.9x | -0.83 | ₩12,520 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmicell | Seoul | Healthcare | Pharmaceuticals | ₩642.04B | -19x | ₩11,350 | 6.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Binex | KOSDAQ | Healthcare | Pharmaceuticals | ₩561.47B | -27.8x | -2.62 | ₩17,630 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Humedix | KOSDAQ | Healthcare | Pharmaceuticals | ₩560.38B | 56.6x | ₩62,400 | 14.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Huons Global | KOSDAQ | Healthcare | Pharmaceuticals | ₩546.27B | 33.7x | -0.53 | ₩44,850 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩505.86B | 10x | 0.2 | ₩28,700 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jw Pharmac | Seoul | Healthcare | Pharmaceuticals | ₩505.86B | 10x | 0.2 | ₩22,250 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
JW Pharmaceutical | Seoul | Healthcare | Pharmaceuticals | ₩505.86B | 10x | 0.2 | ₩59,900 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eubiologics | KOSDAQ | Healthcare | Pharmaceuticals | ₩500.65B | ₩13,670 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 9.7% Upside | Upgrade to Pro+ | |||
Qurient | KOSDAQ | Healthcare | Pharmaceuticals | ₩485.52B | -0.76 | ₩12,460 | -2.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Inventage Lab | KOSDAQ | Healthcare | Pharmaceuticals | ₩455.47B | ₩42,450 | -2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Komipharm Intl | KOSDAQ | Healthcare | Pharmaceuticals | ₩453.4B | 96.2x | 5.74 | ₩6,450 | 1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
HLB Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩445.35B | -5.5x | 0.01 | ₩3,655 | 1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Dong-A St | Seoul | Healthcare | Pharmaceuticals | ₩408.47B | -21.1x | 0.21 | ₩44,600 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Kolon Life Science | KOSDAQ | Healthcare | Pharmaceuticals | ₩381.4B | -17.8x | -0.23 | ₩30,700 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivozon Healthcare | KOSDAQ | Healthcare | Pharmaceuticals | ₩381.04B | -21.4x | ₩7,690 | 4.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Yungjin Pharm | Seoul | Healthcare | Pharmaceuticals | ₩371.27B | 38.2x | ₩2,040 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Huons | KOSDAQ | Healthcare | Pharmaceuticals | ₩359.43B | 10.6x | -1.05 | ₩30,850 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellbion | KOSDAQ | Healthcare | Pharmaceuticals | ₩357.65B | -49.8x | 2.05 | ₩22,000 | -21.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |